These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15277346)

  • 1. Development of an ELISA for measurement of BCAR1 protein in human breast cancer tissue.
    Grebenchtchikov N; Brinkman A; van Broekhoven SP; de Jong D; Geurts-Moespot A; Span PN; Peters HA; Portengen H; Foekens JA; Sweep CG; Dorssers LC
    Clin Chem; 2004 Aug; 50(8):1356-63. PubMed ID: 15277346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.
    van der Flier S; Brinkman A; Look MP; Kok EM; Meijer-van Gelder ME; Klijn JG; Dorssers LC; Foekens JA
    J Natl Cancer Inst; 2000 Jan; 92(2):120-7. PubMed ID: 10639513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of BCAR1 in patients with primary breast cancer.
    Dorssers LC; Grebenchtchikov N; Brinkman A; Look MP; van Broekhoven SP; de Jong D; Peters HA; Portengen H; Meijer-van Gelder ME; Klijn JG; van Tienoven DT; Geurts-Moespot A; Span PN; Foekens JA; Sweep FC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6194-202. PubMed ID: 15448007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue.
    van der Flier S; van der Kwast TH; Claassen CJ; Timmermans M; Brinkman A; Henzen-Logmans SC; Foekens JA; Dorssers LC
    Int J Biol Markers; 2001; 16(3):172-8. PubMed ID: 11605729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas.
    van der Flier S; Chan CM; Brinkman A; Smid M; Johnston SR; Dorssers LC; Dowsett M
    Int J Cancer; 2000 Sep; 89(5):465-8. PubMed ID: 11008210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.
    Dorssers LC; Grebenchtchikov N; Brinkman A; Look MP; Klijn JG; Geurts-Moespot A; Span PN; Foekens JA; Sweep CG
    Clin Chem; 2004 Aug; 50(8):1445-7. PubMed ID: 15166112
    [No Abstract]   [Full Text] [Related]  

  • 7. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
    Brinkman A; van der Flier S; Kok EM; Dorssers LC
    J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
    Brinkman A; de Jong D; Tuinman S; Azaouagh N; van Agthoven T; Dorssers LC
    Breast Cancer Res Treat; 2010 Apr; 120(2):401-8. PubMed ID: 19412734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer anti-estrogen resistance protein 1 (BCAR1/p130cas) in pulmonary disease tissue and serum.
    Deng B; Huang W; Tan QY; Fan XQ; Jiang YG; Liu L; Zhong YY; Liang YG; Wang RW
    Mol Diagn Ther; 2011 Feb; 15(1):31-40. PubMed ID: 21469768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
    Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
    Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of breast cancer anti-estrogen resistance 1 in relation to vascular endothelial growth factor, p53, and prognosis in esophageal squamous cell cancer.
    Huang W; Deng B; Wang RW; Tan QY; Jiang YG
    Dis Esophagus; 2013 Jul; 26(5):528-37. PubMed ID: 22816673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
    Heumann A; Heinemann N; Hube-Magg C; Lang DS; Grupp K; Kluth M; Minner S; Möller-Koop C; Graefen M; Heinzer H; Tsourlakis MC; Wilczak W; Wittmer C; Jacobsen F; Huland H; Simon R; Schlomm T; Sauter G; Steurer S; Lebok P; Hinsch A
    BMC Cancer; 2018 Jan; 18(1):37. PubMed ID: 29304771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids.
    Kishi T; Grass L; Soosaipillai A; Shimizu-Okabe C; Diamandis EP
    Clin Chem; 2003 Jan; 49(1):87-96. PubMed ID: 12507964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status.
    Thomas MD; McIntosh GG; Anderson JJ; McKenna DM; Parr AH; Johnstone R; Lennard TW; Horne CH; Angus B
    J Clin Pathol; 1997 Feb; 50(2):143-7. PubMed ID: 9155696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ELISA for quantitation of human urokinase receptor (CD87) in cancer.
    Kotzsch M; Luther T; Harbeck N; Ockert D; Lutz V; Noack F; Grossmann D; Albrecht S; Kramer MD; Lossnitzer A; Grosser M; Schmitt M; Magdolen V
    Int J Oncol; 2000 Oct; 17(4):827-34. PubMed ID: 10995898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes.
    Pavanelli AC; Mangone FR; Yoganathan P; Bessa SA; Nonogaki S; de Toledo Osório CAB; de Andrade VP; Soares IC; de Mello ES; Mulligan LM; Nagai MA
    Breast Cancer Res Treat; 2022 Feb; 192(1):43-52. PubMed ID: 35031902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.
    Schrecengost RS; Riggins RB; Thomas KS; Guerrero MS; Bouton AH
    Cancer Res; 2007 Jul; 67(13):6174-82. PubMed ID: 17616674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion.
    Guo AK; Itahana Y; Seshachalam VP; Chow HY; Ghosh S; Itahana K
    Br J Cancer; 2021 Jan; 124(1):299-312. PubMed ID: 33144694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of patient-specific assay interference in different formats of enzyme-linked immunoassays for therapeutic monoclonal antibodies.
    Grebenchtchikov N; Geurts-Moespot AJ; Heijmen L; van Laarhoven HW; van Herpen CM; Thijs AM; Span PN; Sweep FC
    Ther Drug Monit; 2014 Dec; 36(6):765-70. PubMed ID: 24819968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.